Panel session, WODC Europe, 2024
Panelists
- Yan Le Cam (VOZ Advisors)
- Prof. Lotte Steuten (OHE)
- Stefano Romanelli (EUCOPE)
Moderator
- Thomas Broekhoff (hollanbio)
Related articles
Access to multi-indication medicines in underserved autoimmune diseases: Are there better approaches to supporting sustainable access?
Multi-indication Medicines15/12/2025
Supporting patients with underserved autoimmune diseases: Challenges and opportunities for innovative medicines
Multi-indication Medicines14/09/2025
Pricing and reimbursement of multiple indication medicines: Can a balance be found between different stakeholder perspectives to optimise value and access for patients, while ensuring sustainable and affordable innovation?
Multi-indication Medicines17/11/2024